English

MediXall Group, Inc.

EDGAR

Quarterly report (10-Q) · filed 2025-09-08

50 filing records in this dataset, filed from 2014-03-05 to 2025-09-08. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

38.9 thousand USD

2024 Q3 · USD

Exact inputs and evidence

Revenue: 38858 USD Source

Net margin

678.92%

2024 Q3 · %

Exact inputs and evidence

Net Income: 263813 USD Source
Revenue: 38858 USD Source

Operating cash flow

-398 thousand USD

2024 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -1000828 USD Source
Operating Cash Flow: -603086 USD Source

Cash and cash equivalents: 572 thousand USD 2020-06-30 Source
Exact value

572426 USD
Long-term debt including current maturities: Not available
Shares outstanding: 169 million shares 2024-09-30 Source
Exact value

168865165 shares

Reported share-count change

29.41% · 38.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

130487491 shares · 2023-09-30· Source
168865165 shares · 2024-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

304 thousand USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Revenue: 309422 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 214925 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 118142 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 52839 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 38858 USD · 2024-07-01 – 2024-09-30 Source

Net income

-2.16 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Net income: -4563406 USD · 2023-01-01 – 2023-12-31 Source
Net income: -3108940 USD · 2023-01-01 – 2023-09-30 Source
Net income: -486600 USD · 2024-01-01 – 2024-03-31 Source
Net income: -485862 USD · 2024-04-01 – 2024-06-30 Source
Net income: 263813 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

-1.2 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Operating cash flow: -1229546 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -1028100 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -308848 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -603086 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -308848 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -1000828 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -603086 USD · 2024-01-01 – 2024-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-09-08.

Financial data available through: 2023-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2023-12-31
Operating income: 2 of 11 periods available· newest 2014-12-31
Net income: 11 of 11 periods available· newest 2023-12-31
Operating cash flow: 11 of 11 periods available· newest 2023-12-31
capital expenditure: No compatible figures in this window
Total assets: 8 of 11 periods available· newest 2023-12-31
Total liabilities: 7 of 11 periods available· newest 2023-12-31
Current assets: 8 of 11 periods available· newest 2023-12-31
Current liabilities: 8 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2019-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+422.1%

Prior period

USD 59,268

2022-01-01 – 2022-12-31
Current period

USD 309,422

2023-01-01 – 2023-12-31

Exact inputs and evidence

309422 − 59268 = 250154 USD

59268 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
309422 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MediXall Group, Inc. · 2023-12-31 MediXall Group, Inc. (edgar:1601280) Year-over-year change in Revenue: 250154 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 309422 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#633786 Filing: 000107997325000141 Input fundies:Revenue: 59268 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#634310 Filing: 000107997325000141
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.27 million

Prior period

−USD 6.83 million

2022-01-01 – 2022-12-31
Current period

−USD 4.56 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-4563406 − -6830415 = 2267009 USD

-6830415 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-4563406 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MediXall Group, Inc. · 2023-12-31 MediXall Group, Inc. (edgar:1601280) Year-over-year change in Net income: 2267009 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4563406 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#820924 Filing: 000107997325000141 Input fundies:NetIncome: -6830415 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#821370 Filing: 000107997325000141
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.33 million

Prior period

−USD 3.56 million

2022-01-01 – 2022-12-31
Current period

−USD 1.23 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-1229546 − -3561083 = 2331537 USD

-3561083 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-1229546 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MediXall Group, Inc. · 2023-12-31 MediXall Group, Inc. (edgar:1601280) Year-over-year change in Operating cash flow: 2331537 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1229546 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#746788 Filing: 000107997325000141 Input fundies:OperatingCashFlow: -3561083 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#747261 Filing: 000107997325000141
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 309,422 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 4.56 million −1,475% of revenue

Cash

Operating cash flow −USD 1.23 million −397% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	22232	Unavailable	Unavailable	Unavailable	-1557405	Unavailable	Source 2017-01-01 – 2017-12-31: 22232 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -1557405 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -2219883 USD Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	1858	Unavailable	Unavailable	Unavailable	-2983429	Unavailable	Source 2018-01-01 – 2018-12-31: 1858 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -2983429 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -2225241 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	2685	Unavailable	Unavailable	Unavailable	-3420951	Unavailable	Source 2019-01-01 – 2019-12-31: 2685 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -3420951 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -2342044 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	0	Unavailable	Unavailable	Unavailable	-5932032	Unavailable	Source 2020-01-01 – 2020-12-31: 0 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -5932032 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -4126869 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	180714	Unavailable	Unavailable	Unavailable	-6200574	Unavailable	Source 2021-01-01 – 2021-12-31: 180714 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -6200574 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -4685270 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	59268	Unavailable	Unavailable	Unavailable	-6830415	Unavailable	Source 2022-01-01 – 2022-12-31: 59268 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -6830415 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -3561083 USD Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	309422	Unavailable	Unavailable	Unavailable	-4563406	Unavailable	Source 2023-01-01 – 2023-12-31: 309422 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -4563406 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -1229546 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 309.4K 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Revenue	42500	Revenue: 42500 Open source
20172017-12-31	Revenue	22232	Revenue: 22232 Open source
20182018-12-31	Revenue	1858	Revenue: 1858 Open source
20192019-12-31	Revenue	2685	Revenue: 2685 Open source
20202020-12-31	Revenue	0	Revenue: 0 Open source
20212021-12-31	Revenue	180714	Revenue: 180714 Open source
20222022-12-31	Revenue	59268	Revenue: 59268 Open source
20232023-12-31	Revenue	309422	Revenue: 309422 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

422.1% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	No prior comparable period	Revenue: 42500 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 22232 Open source
20182018-12-31	Year over year	-91.6%	Revenue: 1858 Open source Revenue: 22232 Open source
20192019-12-31	Year over year	44.5%	Revenue: 2685 Open source Revenue: 1858 Open source
20202020-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 2685 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 180714 Open source Revenue: 0 Open source
20222022-12-31	Year over year	-67.2%	Revenue: 59268 Open source Revenue: 180714 Open source
20232023-12-31	Year over year	422.1%	Revenue: 309422 Open source Revenue: 59268 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,303.7% 2013

Net margin -1,474.8% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Operating margin	-2,303.7%	Operating Income: -979061 Open source Revenue: 42500 Open source
2017-12-31	Operating margin	Not reported	Revenue: 22232 Open source
2018-12-31	Operating margin	Not reported	Revenue: 1858 Open source
2019-12-31	Operating margin	Not reported	Revenue: 2685 Open source
2020-12-31	Operating margin	Not reported	Revenue: 0 Open source
2021-12-31	Operating margin	Not reported	Revenue: 180714 Open source
2022-12-31	Operating margin	Not reported	Revenue: 59268 Open source
2023-12-31	Operating margin	Not reported	Revenue: 309422 Open source
20132013-12-31	Net margin	-2,325.2%	Net Income: -988193 Open source Revenue: 42500 Open source
20172017-12-31	Net margin	-7,005.2%	Net Income: -1557405 Open source Revenue: 22232 Open source
20182018-12-31	Net margin	-160,572.1%	Net Income: -2983429 Open source Revenue: 1858 Open source
20192019-12-31	Net margin	-127,409.7%	Net Income: -3420951 Open source Revenue: 2685 Open source
20202020-12-31	Net margin	Not reported	Net Income: -5932032 Open source Revenue: 0 Open source
20212021-12-31	Net margin	-3,431.2%	Net Income: -6200574 Open source Revenue: 180714 Open source
20222022-12-31	Net margin	-11,524.6%	Net Income: -6830415 Open source Revenue: 59268 Open source
20232023-12-31	Net margin	-1,474.8%	Net Income: -4563406 Open source Revenue: 309422 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 42500 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 22232 Open source Operating Cash Flow: -2219883 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 1858 Open source Operating Cash Flow: -2225241 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 2685 Open source Operating Cash Flow: -2342044 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -4126869 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 180714 Open source Operating Cash Flow: -4685270 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 59268 Open source Operating Cash Flow: -3561083 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 309422 Open source Operating Cash Flow: -1229546 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.2M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Operating cash flow	Not reported	No source recorded
20172017-12-31	Operating cash flow	-2219883	Operating Cash Flow: -2219883 Open source
20182018-12-31	Operating cash flow	-2225241	Operating Cash Flow: -2225241 Open source
20192019-12-31	Operating cash flow	-2342044	Operating Cash Flow: -2342044 Open source
20202020-12-31	Operating cash flow	-4126869	Operating Cash Flow: -4126869 Open source
20212021-12-31	Operating cash flow	-4685270	Operating Cash Flow: -4685270 Open source
20222022-12-31	Operating cash flow	-3561083	Operating Cash Flow: -3561083 Open source
20232023-12-31	Operating cash flow	-1229546	Operating Cash Flow: -1229546 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Free cash flow	Unavailable	No source recorded
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2219883 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2225241 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2342044 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4126869 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4685270 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -3561083 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1229546 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

3,343.9% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2013-12-31	Liabilities / assets	Not reported	Total Assets: 45479 Open source
20172017-12-31	Liabilities / assets	98.5%	Total Liabilities: 382352 Open source Total Assets: 388122 Open source
20182018-12-31	Liabilities / assets	25.5%	Total Liabilities: 185759 Open source Total Assets: 728720 Open source
20192019-12-31	Liabilities / assets	57.6%	Total Liabilities: 540220 Open source Total Assets: 937980 Open source
20202020-12-31	Liabilities / assets	76.8%	Total Liabilities: 1261555 Open source Total Assets: 1643459 Open source
20212021-12-31	Liabilities / assets	130.1%	Total Liabilities: 1471703 Open source Total Assets: 1131581 Open source
20222022-12-31	Liabilities / assets	525.7%	Total Liabilities: 4531378 Open source Total Assets: 862013 Open source
20232023-12-31	Liabilities / assets	3,343.9%	Total Liabilities: 6724659 Open source Total Assets: 201103 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Current assets / current liabilities	0.1×	Current Assets: 45479 Open source Current Liabilities: 453896 Open source
20172017-12-31	Current assets / current liabilities	0.56×	Current Assets: 213231 Open source Current Liabilities: 382352 Open source
20182018-12-31	Current assets / current liabilities	1.95×	Current Assets: 362099 Open source Current Liabilities: 185759 Open source
20192019-12-31	Current assets / current liabilities	0.9×	Current Assets: 446219 Open source Current Liabilities: 493943 Open source
20202020-12-31	Current assets / current liabilities	1.01×	Current Assets: 1133762 Open source Current Liabilities: 1121209 Open source
20212021-12-31	Current assets / current liabilities	0.28×	Current Assets: 342945 Open source Current Liabilities: 1225330 Open source
20222022-12-31	Current assets / current liabilities	0×	Current Assets: 11499 Open source Current Liabilities: 4341921 Open source
20232023-12-31	Current assets / current liabilities	0×	Current Assets: 14205 Open source Current Liabilities: 6698196 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	−USD 684,087 Exact value Exact value: -684087 USD 2014-01-01 – 2014-12-31: -684087 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2014-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -684087 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -684087 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335016002592/crcx-20160930.xml#13943 Filing: 000155335016002592 The citation records this snapshot. The page link may show a newer release later.	−USD 48,441 Exact value Exact value: -48441 USD 2014-01-01 – 2014-12-31: -48441 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2014-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -48441 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48441 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335016001947/crcx-20151231.xml#142255 Filing: 000155335016001947 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 348,621 Exact value Exact value: -348621 USD 2015-01-01 – 2015-12-31: -348621 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2015-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -348621 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -348621 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335017000330/mdxl-20161231.xml#35595 Filing: 000155335017000330 The citation records this snapshot. The page link may show a newer release later.	USD 24,622 Exact value Exact value: 24622 USD 2015-01-01 – 2015-12-31: 24622 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2015-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: 24622 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24622 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335017000330/mdxl-20161231.xml#50927 Filing: 000155335017000330 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 657,160 Exact value Exact value: -657160 USD 2016-01-01 – 2016-12-31: -657160 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2016-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -657160 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -657160 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335018000182/mdxl-20171231.xml#41332 Filing: 000155335018000182 The citation records this snapshot. The page link may show a newer release later.	−USD 666,154 Exact value Exact value: -666154 USD 2016-01-01 – 2016-12-31: -666154 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2016-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -666154 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -666154 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335018000182/mdxl-20171231.xml#209880 Filing: 000155335018000182 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 1.56 million Exact value Exact value: -1557405 USD 2017-01-01 – 2017-12-31: -1557405 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2017-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -1557405 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1557405 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335019001131/mdxl-20181231.xml#56164 Filing: 000155335019001131 The citation records this snapshot. The page link may show a newer release later.	−USD 2.22 million Exact value Exact value: -2219883 USD 2017-01-01 – 2017-12-31: -2219883 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2017-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -2219883 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2219883 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335019001131/mdxl-20181231.xml#142931 Filing: 000155335019001131 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 2.98 million Exact value Exact value: -2983429 USD 2018-01-01 – 2018-12-31: -2983429 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2018-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -2983429 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2983429 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335020000442/mdxl-20191231.xml#27126 Filing: 000155335020000442 The citation records this snapshot. The page link may show a newer release later.	−USD 2.23 million Exact value Exact value: -2225241 USD 2018-01-01 – 2018-12-31: -2225241 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2018-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -2225241 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2225241 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335020000442/mdxl-20191231.xml#53465 Filing: 000155335020000442 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 3.42 million Exact value Exact value: -3420951 USD 2019-01-01 – 2019-12-31: -3420951 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2019-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -3420951 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3420951 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335021000523/mdxl-20201231.xml#90248 Filing: 000155335021000523 The citation records this snapshot. The page link may show a newer release later.	−USD 2.34 million Exact value Exact value: -2342044 USD 2019-01-01 – 2019-12-31: -2342044 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2019-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -2342044 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2342044 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000155335021000523/mdxl-20201231.xml#56013 Filing: 000155335021000523 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 5.93 million Exact value Exact value: -5932032 USD 2020-01-01 – 2020-12-31: -5932032 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2020-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -5932032 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5932032 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997322000448/mdxl_10k.htm#599727 Filing: 000107997322000448 The citation records this snapshot. The page link may show a newer release later.	−USD 4.13 million Exact value Exact value: -4126869 USD 2020-01-01 – 2020-12-31: -4126869 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2020-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -4126869 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4126869 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997322000448/mdxl_10k.htm#611213 Filing: 000107997322000448 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 6.2 million Exact value Exact value: -6200574 USD 2021-01-01 – 2021-12-31: -6200574 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2021-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -6200574 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6200574 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997323001099/mdxl_10k.htm#722410 Filing: 000107997323001099 The citation records this snapshot. The page link may show a newer release later.	−USD 4.69 million Exact value Exact value: -4685270 USD 2021-01-01 – 2021-12-31: -4685270 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2021-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -4685270 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4685270 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997323001099/mdxl_10k.htm#649120 Filing: 000107997323001099 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 6.83 million Exact value Exact value: -6830415 USD 2022-01-01 – 2022-12-31: -6830415 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2022-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -6830415 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6830415 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#821370 Filing: 000107997325000141 The citation records this snapshot. The page link may show a newer release later.	−USD 3.56 million Exact value Exact value: -3561083 USD 2022-01-01 – 2022-12-31: -3561083 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2022-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -3561083 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3561083 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#747261 Filing: 000107997325000141 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 4.56 million Exact value Exact value: -4563406 USD 2023-01-01 – 2023-12-31: -4563406 USD Inspect Net Income Open source Share or cite Citation for Net Income · MediXall Group, Inc. · 2023-12-31 MediXall Group, Inc. (edgar:1601280) Net Income: -4563406 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4563406 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#820924 Filing: 000107997325000141 The citation records this snapshot. The page link may show a newer release later.	−USD 1.23 million Exact value Exact value: -1229546 USD 2023-01-01 – 2023-12-31: -1229546 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MediXall Group, Inc. · 2023-12-31 MediXall Group, Inc. (edgar:1601280) Operating Cash Flow: -1229546 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1601280/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1229546 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1601280/000107997325000141/mdxl_10k-123123.htm#746788 Filing: 000107997325000141 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

50 filings · 1,730 latest values · 1,730 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001601280, 1601280, edgar:1601280

Also known as CONTINENTAL RAIL CORP, MediXall Group, Inc.

MediXall Group, Inc.

Latest quarter

Revenue

Net margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation